This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Today Wikifactory , billing itself as a “GitHub for hardware”, announced it has closed a $3 million funding round, taking it to a total of $4.5M, pre-series A. This allows product developers to review and discuss 3D models in more than 30 file formats in real time. Perhaps that day is edging closer.
Stämm Biotech , founded in 2014, is developing a desktop-sized bioreactor that looks pretty different from the tanks, tubes and knobs traditionally seen in industrial or even benchtop bioreactors. Instead, it’s developing a unit that 3D prints a dense network of microchannels that pass cells through the nutrients and oxygen they need.
Lambda , $480M, artificial intelligence: Lambda, which offers cloud computing services and hardware for training artificial intelligence software, raised a $480 million Series D co-led by Andra Capital and SGW. Lambda is also a provider of the latest GPUs by Nvidia , which are highly sought after by AI developers. billion valuation.
The whole human proteome may be free to browse thanks to DeepMind , but at the bleeding edge of biotech new proteins are made and tested every day, a complex and time-consuming process. Going from service to hardware sales and support is the current roadmap. “My co-founder [Estandian] developed ClickP himself.
By Caleb Appleton Having invested in the biotech space since before it had a name, Ive seen life sciences investors steer founders toward a therapeutics pipeline in hopes of securing the payout of a winning drug or medical device. Does the market see value in the tool today, or do you need to educate?
Fleetio , $450M, fleet management: Fleet optimization software platform developer Fleetio locked up a $450 million round to finance the acquisition of maintenance authorization platform Auto Integrate. Island , $250M, cybersecurity: Dallas-based enterprise browser developer Island raised a $250 million Series E at a $4.8
The week was especially good for biotech, which led the way with two big raises. Tome Biosciences , $213M, biotech: A big biotech raise hit high on the list this week. The company plans to use the tech to develop gene therapies for monogenic liver diseases and cell therapies for autoimmune diseases.
Startups developing so-called deep tech often find it challenging to raise capital for various reasons. Pae Wu and Garrett Winther are both partners at SOSV and run the fund’s programs around biotech and hardware. Before giving advice, the two acknowledged the nuances across the deep tech ecosystem and each industry.
The world’s labs are under pressure to do more tests and process more materials, not just due to COVID but from the growing biotech and drug development sectors — and automation is the sure path forwards. “We’ve had to build an entirely new hardware stack that allows for this kind of automation,” ElSayed said.
Deep tech, medtech/biotech, climate tech, and crypto and blockchain are all areas that investors say they’re either actively investing in or watching for signs of scale. Outset-backed Zenno Astronautics, for example, is developing a fuel-free satellite propulsion system that uses magnets powered by solar panels.
Stability AI , the venture-backed startup behind the text-to-image AI system Stable Diffusion, is funding a wide-ranging effort to apply AI to the frontiers of biotech. “ Stability looks to develop and democratize AI, and through OpenBioML, we see an opportunity to advance the state of the art in sciences, health and medicine.”
The Dallas-based startup, which launched in 2021, plans to use the money to continue to advance its genetic engineering technologies, as well as grow its software and hardware solutions for applications involved with de-extinction, conservation and human health care.
NextMind debuted its Dev Kit hardware at CES last year, but the hardware is now actually shipping out , and the startup shared with me the production version to take a test drive. The basics. The basics. Bottom line. NextMind’s Dev Kit is definitely just that – a Dev Kit.
Hong Kong-based drug discovery and development company Insilico has secured fresh capital at a time that its CEO described as a “biotech winter.” while hardware production happened in China. When asked why the company straddles China and the U.S.,
a biotech company focused on developing “organ-on-a-chip” technology, closed an $82 million Series E round on Tuesday. This latest round is intended to formulate a massive investment in a “roadmap” for developing model organ systems created to fit drugmakers’ needs and bring the idea of an organ-on-a-chip into use in the lab. .
The pre-seed round was led by Latin America-focused biotech investor Zentynel Frontier Investments , with participation from academic incubation investors VentureWell , mission-driven impact investor ImpactAssets and a few additional angels from the United States and Latin America. .”
Another big week for biotech, as startups in the sector scooped up multiple spots on this week’s list. Seaport Therapeutics , $225M, biotech: Seaport Therapeutics isn’t new to this list. The biotech company focuses on medicines for depression, anxiety and other neuropsychiatric disorders. billion post-money valuation.
Not exactly sure what was in the water this week, but AI and biotech led the way as happens often. The company offers cloud computing services and hardware for training artificial intelligence software. The company offers cloud computing services and hardware for training artificial intelligence software. billion valuation.
Once again, biotech made up nearly a third of the list while some other sectors that don’t usually make the list — developer platform and analytics — were represented. Uniquity Bio , $300M, biotech: It has become pretty much the norm to start off these lists with a big biotech raise. billion valuation led by GGV Capital.
Healthcare and AI lead The leading sector for investment was healthcare and biotech companies which raised $6 billion. Large AI rounds were raised by model developers Beijing-based Baichuan Intelligence with $687 million and Toronto-based Cohere at $500 million , and Berlin-based AI-defense company Helsing raised $489 million.
Turns out healthy habits are a lot harder to develop than good ones. I’ve tried a few different pieces of meditation hardware over the years, because who wouldn’t love to have a nice shortcut to mindfulness? million Series C, led by BDC Capital, Sonny Vu’s Alabaster and Export Development Canada. that affect it.
Key Takeaways from BioTechX 2024: A Shift Towards Realism and Practical Applications Capgemini Nov 6, 2024 Facebook Linkedin The BioTechX event in Basel in October was a major gathering for biotech and pharma professionals. This year, there was a different vibe compared to last year. Nevertheless, it is crucial to start now.
Cellino , a company developing a platform to automate stem cell production, presented today at TechCrunch Disrupt 2021 to detail how its system, which combines A.I. technology, machine learning, hardware, software — and yes, lasers! — could eventually democratize access to cell therapies. in Physics.
Automated driving company Wayve , data preparation company Scale AI and AI biotech company Xaira Therapeutics each raised billion-dollar rounds. Healthcare and biotech was the second-largest sector, raising $17 billion. Hardware companies — in large part due to AI infrastructure and semiconductor fundings — raised $11 billion.
Andreessen co-led the Series B in AI voice software developer ElevenLabs with angel investors Nat Friedman and Daniel Gross. in H1 2024 was concentrated in larger bets, and in two leading industries, healthcare/biotech and AI, according to an analysis of Crunchbase data. investor, we find a very different picture.
The company continued hiring developers and marketers and raised the team by around 10%. Developed a SaaS-based white-label web3 platform that opens revenue streams and strengthens community engagement. Ahrefs claims to have become a $100 million company in annual revenue without venture capital. Incorporated in Delaware, USA.
But much of the industry is still in its infancy, partly because of a lack of domain experts and software tools that match the progress of quantum hardware. Now companies are working to simplify the process of developing quantum software applications so programmers don’t actually need to understand the underlying quantum mechanics.
The San Jose, California-based startup has developed a solid-state active cooling chip — AirJet — that allows users to leverage AI even on the edge of networks or on edge devices. CinRx Pharma , $73M, biotech: This week’s top biotech round isn’t as big as it is on most weeks, but that follows the general trend. billion upfront.
However, they seem to think it’s weaker in design, hardware, fintech, robotics and agritech. The investment scene is described variously as focusing on software, clean tech, life sciences, biotech, organoids, 3D bioprinting, AI and VR/AR. Strong: tech development in general, specifically software, clean tech, marketplace, deep tech.
Artificial , which has built a software platform for laboratories to assist with, or in some cases fully automate, research and development work, has raised $21.5 The company already has a number of customers including Thermo Fisher and Beam Therapeutics using its software directly and in partnership for their own customers.
One is a company focusing on cancer care and neurological disorders, which has been using Volta’s tech to develop a DNA extraction process. The fourth company is a biotech firm interested in synthetic biology. One is a research institution in RNA applications. The third is a “genome center,” he says.
In addition to the standard array of wearable sensors, the startup points to a custom-built EDA (electrodermal activity) detector as the product’s hardware differentiator. Funding went to research development and manufacturing of, really, a best in class wearable device,” says Freckleton. Mindfulness content is limited.
Big deals The largest startup funding round in April was a $1 billion deal to stealth startup Xaira Therapeutics for drug development using AI. Top sectors Biotech and healthcare was the leading sector by funding amount in April. Other leading sectors in April include hardware startups, which collectively raised $3.3
It’s in the process of developing new tools that give surgeons the ability to see otherwise invisible structures, and has plans to roll out those tools in the coming months. . The hardware, which received FDA 510(k) clearance in April of 2021 , fits between any type of endoscope and a white light camera system. .
” The array they’ve developed is called Layer 7, a reference to the fact that the cortex itself has six layers, which the interface sits on top of. It’s a full-stack product that requires an interdisciplinary team to develop,” Mager said. “And then you have to take it through the FDA regulatory process.”
The company is developing AI-enhanced robots that it hopes will be able to perform dangerous jobs and alleviate labor shortages. The company offers cloud computing services and hardware for training artificial intelligence software. The startup is a provider of Nvidia ’s latest GPUs, which are highly sought after by AI developers.
Last quarter, AI outstripped healthcare and biotech ($15 billion invested in Q3), hardware ($13 billion), and financial services and fintech ($8 billion), Crunchbase data shows. Though that’s below the $23.4
Eko’s hardware consists of digital stethoscopes that boast a few basic bells and whistles, like noise-canceling technology or the ability to record and visualize heartbeats. Eko has been working toward developing machine learning-based analysis capability. But so far, the company has focused on devices and clinical tools.
Founded in 2012, the accelerator is focused on developing early-stage companies tied to the University of California system. Building on technologies developed in the stem cell research labs of UCSF, EndoCrine is looking to commercialize a better way to discover and develop drugs. Image Credits: EndoCrine Bio, Inc. Serinus Labs.
The startup has developed phytosterol-based solutions to help plants adapt better to climate change. The company plans to use the money to fuel the growth of its LaserWeeder software and hardware product. However, its not just that Pairwise is developing seedless fruits. As the world changes, our food needs to follow suit.
In addition, the firm led smaller rounds for AI cancer treatment startup Valar Labs , weapon targeting company ZeroMark , and Rollup , a collaborative platform for hardware. The San Francisco-based startup develops software that uses AI to automate radiology report writing. It also led a $26.5
Scopio has developed a scanner, called Scopio100x , capable of imaging that whole blood sample, while maintaining the ability to achieve 100x magnification. And other companies have already looked to develop imaging tools that can make that manual review faster, and more automated.
Nathan was working for a biotech company that had hit that phase. Roy was an engineer and software developer, and Roy could build them a custom robot for much cheaper. Nathan examined the hardware while Roy continued his explanation. "So, The cash crunch starts, and what happens next can often make or break the company.
Research and development equipment. Agri-tech entrepreneurs have developed an innovative IoT based software, that can track weather conditions and provide accurate information about the quality and type of soil. Agricultural biotechnology also helps in the development of innovative foods. Automated irrigation. Farm robotics.
We organize all of the trending information in your field so you don't have to. Join 49,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content